Severe Phenotype in an Apparent Homozygosity Caused by a Large Deletion in the CFTR Gene: a Case Report
Overview
General Medicine
Authors
Affiliations
Background: Over 1900 mutations have been identified in the cystic fibrosis conductance transmembrane regulator gene, including single nucleotide substitutions, insertions, and deletions. Unidentified mutations may still lie in introns or in regulatory regions, which are not routinely investigated, or in large genomic deletions, which are not revealed by conventional molecular analysis. The apparent homozygosity for a rare, cystic fibrosis conductance transmembrane regulator mutation screened by standard molecular analysis should be further investigated to confirm if the mutation is in fact homozygous. We describe a patient presenting with an apparent homozygous S4X mutation.
Case Presentation: A 13-year-old female patient of African descent with clinical symptoms of classic cystic fibrosis and a positive sweat test (97 mEq/L, diagnosed at age 3 years) presented with pancreatic insufficiency and severe pulmonary symptoms (initial lung colonization with Pseudomonas aeruginosa at age 4 years; forced vital capacity: 69%; forced expiratory volume: 51%; 2011). Furthermore, she developed severe acute lung disease and recurrent episodes of dehydration requiring hospitalization. The girl carried the CFTR mutation S4X in apparent homozygosity. However, further analysis revealed a large deletion in the second allele that included the region of the mutation. The deletion that we describe includes nucleotides 120-142, which correspond to a loss of 23 nucleotides that abolishes the normal translation initiation codon.
Conclusion: This study reiterates the view that large, cystic fibrosis conductance transmembrane regulator deletions are an important cause of severe cystic fibrosis and emphasizes the importance of including large deletions/duplications in cystic fibrosis conductance transmembrane regulator diagnostic tests.
Deng H, Zhang Y, Yao Y, Xiao H, Su B, Xu K Front Pediatr. 2020; 8:165.
PMID: 32363171 PMC: 7180205. DOI: 10.3389/fped.2020.00165.
A comprehensive overview of the cystic fibrosis on the island of São Miguel (Azores, Portugal).
Rosa J, Gaspar-Silva P, Pacheco P, Silva C, Branco C, Vieira B BMC Pediatr. 2020; 20(1):2.
PMID: 31900120 PMC: 6942372. DOI: 10.1186/s12887-019-1903-y.
Carreno-Gago L, Blazquez-Bermejo C, Diaz-Manera J, Camara Y, Gallardo E, Marti R Front Genet. 2019; 10:576.
PMID: 31258551 PMC: 6588129. DOI: 10.3389/fgene.2019.00576.
Martins R, Junior M, Moreira A, Zembrzuski V, Proenca da Fonseca A, Abreu G Mol Genet Genomic Med. 2019; 7(7):e00645.
PMID: 31199594 PMC: 6625342. DOI: 10.1002/mgg3.645.
Differences in gene mutations between Chinese and Caucasian cystic fibrosis patients.
Zheng B, Cao L Pediatr Pulmonol. 2016; 52(3):E11-E14.
PMID: 27717243 PMC: 5324682. DOI: 10.1002/ppul.23539.